Russell Investments Group
JAZZ icon

Russell Investments Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Russell Investments Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Sell
50,750
-4,464
-8% -$978K 0.01% 950
2026
Q1 		$10.4M Buy
55,214
+15,456
+39% +$2.7M 0.01% 916
2025
Q4 		$6.76M Buy
39,758
+18,785
+90% +$2.88M 0.01% 1135
2025
Q3 		$2.76M Sell
20,973
-92,948
-82% -$11.1M ﹤0.01% 1687
2025
Q2 		$12.1M Sell
113,921
-153,451
-57% -$16.7M 0.02% 773
2025
Q1 		$33.2M Buy
267,372
+42,576
+19% +$5.55M 0.05% 426
2024
Q4 		$27.7M Buy
224,796
+34,181
+18% +$4.03M 0.04% 461
2024
Q3 		$21.2M Buy
190,615
+9,209
+5% +$1.01M 0.03% 557
2024
Q2 		$19.4M Sell
181,406
-83,067
-31% -$9.13M 0.03% 540
2024
Q1 		$31.8M Buy
264,473
+21,368
+9% +$2.62M 0.05% 397
2023
Q4 		$29.9M Buy
243,105
+1,201
+0.5% +$150K 0.05% 385
2023
Q3 		$31.3M Buy
241,904
+3,471
+1% +$463K 0.06% 339
2023
Q2 		$29.6M Sell
238,433
-6,587
-3% -$886K 0.06% 384
2023
Q1 		$35.8M Buy
245,020
+26,423
+12% +$3.91M 0.07% 335
2022
Q4 		$34.8M Sell
218,597
-18,749
-8% -$2.75M 0.07% 341
2022
Q3 		$31.6M Sell
237,346
-16,207
-6% -$2.46M 0.07% 339
2022
Q2 		$39.6M Sell
253,553
-22,483
-8% -$3.46M 0.08% 290
2022
Q1 		$43M Sell
276,036
-23,778
-8% -$3.45M 0.07% 319
2021
Q4 		$38.2M Buy
299,814
+7,179
+2% +$943K 0.06% 367
2021
Q3 		$38.1M Buy
292,635
+16,222
+6% +$2.45M 0.06% 365
2021
Q2 		$49.1M Buy
276,413
+30,123
+12% +$5.22M 0.08% 295
2021
Q1 		$40.5M Buy
246,290
+47,050
+24% +$7.74M 0.07% 332
2020
Q4 		$32.9M Sell
199,240
-48,471
-20% -$7.22M 0.07% 341
2020
Q3 		$35.1M Sell
247,711
-21,497
-8% -$2.67M 0.08% 296
2020
Q2 		$29.7M Buy
269,208
+100,926
+60% +$11.2M 0.07% 337
2020
Q1 		$16.8M Sell
168,282
-17,044
-9% -$2.2M 0.04% 458
2019
Q4 		$27.6M Buy
185,326
+18,348
+11% +$2.5M 0.05% 413
2019
Q3 		$21.3M Sell
166,978
-15,740
-9% -$2.11M 0.04% 507
2019
Q2 		$25.8M Sell
182,718
-3,121
-2% -$419K 0.05% 455
2019
Q1 		$26.4M Buy
185,839
+47,163
+34% +$6.15M 0.05% 451
2018
Q4 		$17.1M Buy
138,676
+6,283
+5% +$932K 0.04% 573
2018
Q3 		$22.2M Buy
132,393
+63,963
+93% +$11M 0.04% 532
2018
Q2 		$11.8M Buy
68,430
+36,415
+114% +$5.95M 0.02% 809
2018
Q1 		$4.8M Buy
32,015
+16,983
+113% +$2.49M 0.01% 1385
2017
Q4 		$2.05M Buy
15,032
+1,881
+14% +$261K ﹤0.01% 1802
2017
Q3 		$1.92M Sell
13,151
-3,425
-21% -$518K ﹤0.01% 1805
2017
Q2 		$2.58M Buy
16,576
+1,483
+10% +$227K ﹤0.01% 1588
2017
Q1 		$2.19M Sell
15,093
-13,208
-47% -$1.72M ﹤0.01% 1705
2016
Q4 		$3.04M Buy
+28,301
New +$3.15M 0.01% 1563

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Russell Investments Group's JAZZ Position: Q2 2026 in Review

Russell Investments Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.1% in Q2 2026, selling an estimated $978K and leaving 50,750 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #950.

Russell Investments Group first reported a position in JAZZ in Q4 2016 and has held it in 39 quarters since. The position peaked at $49.1M in Q2 2021. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Russell Investments Group held 50,750 shares of Jazz Pharmaceuticals worth $12.2M as of Q2 2026.
  • Russell Investments Group sold 4,464 Jazz Pharmaceuticals shares in Q2 2026, an estimated $978K.
  • Jazz Pharmaceuticals made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #950 holding.
  • Russell Investments Group first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Jazz Pharmaceuticals position peaked at $49.1M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.